Science Academies Call on G-7 Governments to Take Urgent Action to Accelerate Decarbonization, Develop Antiviral Drugs to Increase Pandemic Preparedness, Address Other Global Challenges
Science academies from the G-7 nations issued statements urging their governments to take action on four global challenges — developing antiviral drugs to prepare for future pandemics, speeding progress on decarbonization, protecting the oceans and sea ice, and implementing a One Health approach to zoonotic disease and antimicrobial resistance. (Source: News from the National Academies)
Source: News from the National Academies - May 31, 2022 Category: Science Source Type: news
HHS: Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
The U.S. Department of Health and Human Services (HHS) will hold a public meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) on September 12-13, 2022. The PACCARB advises and provides information and recommendations to the Secretary of HHS regarding programs and policies intended to reduce or combat antibiotic-resistant bacteria that may present a public health threat. The main focuses of the meeting will be on One Health Antimicrobial resistance (AMR) and pandemic preparedness policy, and the final agenda will be published on thePACCARB website. Pre-registration is required f...
Source: Federal Register updates via the Rural Assistance Center - May 23, 2022 Category: Rural Health Source Type: news
The battle against bugs: Antibacterial resistance grows as funding lags
Boston-area biotechs are working to fight antimicrobial resistance. Time — and funding — is running out. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 20, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news
Tackling antimicrobial resistance 2019 to 2024
This policy paper sets out changes to the commitments in Tackling antimicrobial resistance 2019 to 2024: the UK ’s five-year national action plan, in its third year of delivery. (Source: NHS Networks)
Source: NHS Networks - May 19, 2022 Category: UK Health Source Type: news
Antimicrobial resistance (AMR), DHSC, PHE, Department for Environment, Food & Rural Affairs, and Veterinary Medicines Directorate (updated 16th May 2022)
Information and resources on the UK ' s plans to see antimicrobial resistance contained and controlled by 2040.
16 May 2022Added ' Addendum to the UK 5-year action plan for antimicrobial resistance 2019 to 2024 ' to the ' strategic publications ' section.
31 July 2019Added ' New commitments in the fight against antimicrobial resistance ' to news section. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 17, 2022 Category: Consumer Health News Source Type: news
ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19
This week, PhRMA sponsored The Washington Post ’s event,Coronavirus: Lessons of the Pandemic, where PhRMA president and CEO Stephen J. Ubl shared cruciallessons learned from the pandemic on how to protect patient access to medicine and ensure the health of our robust supply chain. The event also featured PhRMA board member and Genentech CEO Alexander Hardy, who discussed Genentech ’s progress during the pandemic and how to improvehealth equity. (Source: The Catalyst)
Source: The Catalyst - May 13, 2022 Category: Pharmaceuticals Tags: Drug Cost Coronavirus Antimicrobial Resistance Source Type: news
Inhaled antibiotics could help reduce antimicrobial resistance
Using inhaled antibiotics to treat lower respiratory tract infections could help reduce antimicrobial resistance, according to researchers from the Universities of Bristol and Bath. (Source: University of Bristol news)
Source: University of Bristol news - May 12, 2022 Category: Universities & Medical Training Tags: Research, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School Source Type: news
Projections for a Pandemic Future: in Whose Interest?
The World Health Assembly (22-28 May) is expected to discuss the pandemic treaty.Credit: World Health Organization (WHO)By Nicoletta DenticoROME, May 12 2022 (IPS) In what has been defined a historic consensus decision aimed at protecting the world from future infectious diseases crises, on 1st December 2021, the special session of the World Health Assembly agreed to kickstart a global process to draft and negotiate a convention, agreement or other international instrument to strengthen pandemic prevention, preparedness and response.
According to the World Health Organization (WHO) Director-General, the decision marked â€...
Source: IPS Inter Press Service - Health - May 12, 2022 Category: International Medicine & Public Health Authors: Nicoletta Dentico Tags: COVID-19 Featured Global Headlines Health Human Rights Humanitarian Emergencies Poverty & SDGs TerraViva United Nations IPS UN Bureau Source Type: news
Antibiotic Prescribing Practice Varies Widely in Canada Antibiotic Prescribing Practice Varies Widely in Canada
Specific feedback for primary care clinicians could reduce the use of avoidable antibiotics and the potential for the emergence of antimicrobial resistance.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 11, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT
RCT (n=240) found methenamine is not inferior to current standard care (daily 50/100mg nitrofurantoin, 100mg trimethoprim or 250mg cefalexin) in preventing recurrent UTI ' s. Results suggest antimicrobial resistance is proportionally higher in women taking prophylactic antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 11, 2022 Category: Consumer Health News Source Type: news
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19
Since the start of the pandemic, America ’s biopharmaceutical companies haveworked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We ’ve made unprecedented progress with having delivered over 12 billion vaccines globally with another 20 billion expected in 2022. (Source: The Catalyst)
Source: The Catalyst - April 28, 2022 Category: Pharmaceuticals Authors: Gabby Migliara Tags: Research and Development PDUFA Coronavirus Antimicrobial Resistance Source Type: news
Governing Global Antimicrobial Resistance: 6 Key Lessons Governing Global Antimicrobial Resistance: 6 Key Lessons
In this commentary, a panel of 25 scholars call for a coordinated global response to the threat of antimicrobial resistance, modeled after the Paris Climate Agreement.American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 28, 2022 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
Inappropriate Antibiotic Use Increased During Pandemic Inappropriate Antibiotic Use Increased During Pandemic
Compared with the prepandemic period, US hospitals with medium and high rates of antimicrobial resistance showed higher levels of antibiotic use among both SARS-CoV-2 positive and negative patients.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 27, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Antimicrobial resistance (AMR): applying All Our Health, Office for Health Improvement and Disparities (updated 25th April 2022)
Evidence and guidance for healthcare professionals on antimicrobial resistance and stewardship, and infection prevention and control.
25 April 2022Inserted a link to global action plan on antimicrobial resistance, under the ' Promoting the prevention of infections and the reduction of antimicrobial resistance in your professional practice ' section. Updated links to NHS Choices.
17 June 2019Added link to ' All Our Health ' antimicrobial resistance e-learning resource. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 25, 2022 Category: Consumer Health News Source Type: news
Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)
Cape Town, South Africa, April 25, 2022 – Johnson & Johnson (the Company) today announced the launch of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, in Cape Town, South Africa. This marks the latest expansion of the J&J Centers for Global Health Discovery (J&J Centers), a global network of research collaborations between the Company and leading research institutions to accelerate translational and discovery research to address some of the world’s most pressing global health challenges. The Sa...
Source: Johnson and Johnson - April 25, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
